European Archives - Page 1409 of 1560 - European Medical Journal

ESMO Rewards Outstanding Oncologists

Switzerland, September 6, 2016 – The European Society for Medical Oncology (ESMO), the leading professional organisation for medical oncology, has…

ESMO Women for Oncology Awards Sumitra Thongprasert

Switzerland, September 6, 2016 – Professor Sumitra Thongprasert has been awarded the second ESMO Women for Oncology award,1 honouring her position as a…

16th World Congress on Cancers of the Skin & 12th Congress of the European Association of Dermato Oncology (EADO)

Barcelona, September 5, 2016 – Almirall, S.A. (ALM), the global pharmaceutical company based in Barcelona, has announced positive results from a Phase…

The International Liver Cancer Association’s (ILCA) 10th ILCA Annual Conference

Canada, September 9-11, 2016 – We also take this opportunity to personally invite you to attend the 10th ILCA Annual Conference.

Pregnant Mothers Taking Chemotherapy Drug Could Reduce Fertility in Daughters

MOTHERS taking the chemotherapy drug etoposide during pregnancy could reduce the reproductive lifespan of their daughters. This is according to the…

Zika Virus Linked to Physical Deformities in Babies

THE ZIKA virus (ZIKV) infection in pregnant women has been implicated in the development of neurological abnormalities which lead to limb joint…

CDK4 Protein Both a Trigger and Target for Treatment of Liver Disease

SCIENTISTS have identified the CDK4 protein as a trigger for the development of non-alcoholic fatty liver disease (NAFLD) and found that its inhibition…

Burden of Viral Hepatitis Grows

KILLING as many people as tuberculosis, HIV/AIDS, or malaria, hepatitis has risen in worldwide prominence, resulting annually in 1.45 million deaths.

The Evolving Landscape of Rheumatology: Biosimilarity and Extrapolation

Targeted biological therapies have revolutionised the treatment of inflammatory diseases in rheumatology and new agents continue to be developed. The…

EMJ Rheumatology 3 [Suppl 14] 2016

Targeted biological therapies have revolutionised the treatment of inflammatory diseases in rheumatology and new agents continue to be developed.